News
Filter
-
Patients with ultra-rare bone marrow disease set to benefit from £1.15m grant from LifeArc and The Aplastic Anaemia Trust
-
LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases
-
Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
-
LifeArc invests £1.5 million in Ducentis BioTherapeutics
-
LifeArc monetises Keytruda® royalty interests to fund further research and investment
-
Medicines Discovery Catapult and LifeArc launch strategic R&D partnership in biomarker discovery and proteomics technology
-
LifeArc and The University of Kent collaborate to develop potential pain medicines
-
LifeArc licenses lead stage molecules to Daiichi Sankyo
-
Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance
-
Alliance enables clinical trial of experimental treatment for epidermolysis bullosa
-
Melanie Lee, a life in life sciences
-
LifeArc launches Technology Transfer Fellowships
